Report Overview
Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury, and to minimize and/or compensate for any functional alterations resulting from it.
The global Neurorehabilitation Therapy market size was estimated at USD 1053 million in 2023 and is projected to reach USD 2176.17 million by 2032, exhibiting a CAGR of 8.40% during the forecast period.
North America Neurorehabilitation Therapy market size was estimated at USD 315.32 million in 2023, at a CAGR of 7.20% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Neurorehabilitation Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurorehabilitation Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurorehabilitation Therapy market in any manner.
Global Neurorehabilitation Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
VISHEE
Beijing Bo'ai Hospital
Beijing Rehabilitation Hospital of Capital Medical University
NCC
CHIEFTAIN
Tongji Hospital
Haobro Medical Device
DIH
Sun Java
Aoyang Health
PKUCare Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Beijing United Family Rehabilitation Hospital
Bionik Laboratories Corp
BioScience Managers Ltd
Bioventus
DIH (Hocoma AG)
Ekso Bionics Holdings
Eodyne
Neofect
Neuro Rehab VR
Reha Technology AG
Market Segmentation (by Type)
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
Market Segmentation (by Application)
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurorehabilitation Therapy Market
Overview of the regional outlook of the Neurorehabilitation Therapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurorehabilitation Therapy
1.2 Key Market Segments
1.2.1 Neurorehabilitation Therapy Segment by Type
1.2.2 Neurorehabilitation Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurorehabilitation Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Neurorehabilitation Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Neurorehabilitation Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurorehabilitation Therapy Market Competitive Landscape
3.1 Global Neurorehabilitation Therapy Sales by Manufacturers (2019-2025)
3.2 Global Neurorehabilitation Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Neurorehabilitation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurorehabilitation Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Neurorehabilitation Therapy Sales Sites, Area Served, Product Type
3.6 Neurorehabilitation Therapy Market Competitive Situation and Trends
3.6.1 Neurorehabilitation Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurorehabilitation Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurorehabilitation Therapy Industry Chain Analysis
4.1 Neurorehabilitation Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurorehabilitation Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurorehabilitation Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurorehabilitation Therapy Sales Market Share by Type (2019-2025)
6.3 Global Neurorehabilitation Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Neurorehabilitation Therapy Price by Type (2019-2025)
7 Neurorehabilitation Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurorehabilitation Therapy Market Sales by Application (2019-2025)
7.3 Global Neurorehabilitation Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Neurorehabilitation Therapy Sales Growth Rate by Application (2019-2025)
8 Neurorehabilitation Therapy Market Consumption by Region
8.1 Global Neurorehabilitation Therapy Sales by Region
8.1.1 Global Neurorehabilitation Therapy Sales by Region
8.1.2 Global Neurorehabilitation Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Neurorehabilitation Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurorehabilitation Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurorehabilitation Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurorehabilitation Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurorehabilitation Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Neurorehabilitation Therapy Market Production by Region
9.1 Global Production of Neurorehabilitation Therapy by Region (2019-2025)
9.2 Global Neurorehabilitation Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Neurorehabilitation Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Neurorehabilitation Therapy Production
9.4.1 North America Neurorehabilitation Therapy Production Growth Rate (2019-2025)
9.4.2 North America Neurorehabilitation Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Neurorehabilitation Therapy Production
9.5.1 Europe Neurorehabilitation Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Neurorehabilitation Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Neurorehabilitation Therapy Production (2019-2025)
9.6.1 Japan Neurorehabilitation Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Neurorehabilitation Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Neurorehabilitation Therapy Production (2019-2025)
9.7.1 China Neurorehabilitation Therapy Production Growth Rate (2019-2025)
9.7.2 China Neurorehabilitation Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 VISHEE
10.1.1 VISHEE Neurorehabilitation Therapy Basic Information
10.1.2 VISHEE Neurorehabilitation Therapy Product Overview
10.1.3 VISHEE Neurorehabilitation Therapy Product Market Performance
10.1.4 VISHEE Business Overview
10.1.5 VISHEE Neurorehabilitation Therapy SWOT Analysis
10.1.6 VISHEE Recent Developments
10.2 Beijing Bo'ai Hospital
10.2.1 Beijing Bo'ai Hospital Neurorehabilitation Therapy Basic Information
10.2.2 Beijing Bo'ai Hospital Neurorehabilitation Therapy Product Overview
10.2.3 Beijing Bo'ai Hospital Neurorehabilitation Therapy Product Market Performance
10.2.4 Beijing Bo'ai Hospital Business Overview
10.2.5 Beijing Bo'ai Hospital Neurorehabilitation Therapy SWOT Analysis
10.2.6 Beijing Bo'ai Hospital Recent Developments
10.3 Beijing Rehabilitation Hospital of Capital Medical University
10.3.1 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Basic Information
10.3.2 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product Overview
10.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product Market Performance
10.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy SWOT Analysis
10.3.5 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
10.3.6 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
10.4 NCC
10.4.1 NCC Neurorehabilitation Therapy Basic Information
10.4.2 NCC Neurorehabilitation Therapy Product Overview
10.4.3 NCC Neurorehabilitation Therapy Product Market Performance
10.4.4 NCC Business Overview
10.4.5 NCC Recent Developments
10.5 CHIEFTAIN
10.5.1 CHIEFTAIN Neurorehabilitation Therapy Basic Information
10.5.2 CHIEFTAIN Neurorehabilitation Therapy Product Overview
10.5.3 CHIEFTAIN Neurorehabilitation Therapy Product Market Performance
10.5.4 CHIEFTAIN Business Overview
10.5.5 CHIEFTAIN Recent Developments
10.6 Tongji Hospital
10.6.1 Tongji Hospital Neurorehabilitation Therapy Basic Information
10.6.2 Tongji Hospital Neurorehabilitation Therapy Product Overview
10.6.3 Tongji Hospital Neurorehabilitation Therapy Product Market Performance
10.6.4 Tongji Hospital Business Overview
10.6.5 Tongji Hospital Recent Developments
10.7 Haobro Medical Device
10.7.1 Haobro Medical Device Neurorehabilitation Therapy Basic Information
10.7.2 Haobro Medical Device Neurorehabilitation Therapy Product Overview
10.7.3 Haobro Medical Device Neurorehabilitation Therapy Product Market Performance
10.7.4 Haobro Medical Device Business Overview
10.7.5 Haobro Medical Device Recent Developments
10.8 DIH
10.8.1 DIH Neurorehabilitation Therapy Basic Information
10.8.2 DIH Neurorehabilitation Therapy Product Overview
10.8.3 DIH Neurorehabilitation Therapy Product Market Performance
10.8.4 DIH Business Overview
10.8.5 DIH Recent Developments
10.9 Sun Java
10.9.1 Sun Java Neurorehabilitation Therapy Basic Information
10.9.2 Sun Java Neurorehabilitation Therapy Product Overview
10.9.3 Sun Java Neurorehabilitation Therapy Product Market Performance
10.9.4 Sun Java Business Overview
10.9.5 Sun Java Recent Developments
10.10 Aoyang Health
10.10.1 Aoyang Health Neurorehabilitation Therapy Basic Information
10.10.2 Aoyang Health Neurorehabilitation Therapy Product Overview
10.10.3 Aoyang Health Neurorehabilitation Therapy Product Market Performance
10.10.4 Aoyang Health Business Overview
10.10.5 Aoyang Health Recent Developments
10.11 PKUCare Rehabilitation Hospital
10.11.1 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Basic Information
10.11.2 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product Overview
10.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product Market Performance
10.11.4 PKUCare Rehabilitation Hospital Business Overview
10.11.5 PKUCare Rehabilitation Hospital Recent Developments
10.12 Beijing Puhua International Hospital
10.12.1 Beijing Puhua International Hospital Neurorehabilitation Therapy Basic Information
10.12.2 Beijing Puhua International Hospital Neurorehabilitation Therapy Product Overview
10.12.3 Beijing Puhua International Hospital Neurorehabilitation Therapy Product Market Performance
10.12.4 Beijing Puhua International Hospital Business Overview
10.12.5 Beijing Puhua International Hospital Recent Developments
10.13 Xiangyu Medical
10.13.1 Xiangyu Medical Neurorehabilitation Therapy Basic Information
10.13.2 Xiangyu Medical Neurorehabilitation Therapy Product Overview
10.13.3 Xiangyu Medical Neurorehabilitation Therapy Product Market Performance
10.13.4 Xiangyu Medical Business Overview
10.13.5 Xiangyu Medical Recent Developments
10.14 Beijing United Family Rehabilitation Hospital
10.14.1 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Basic Information
10.14.2 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product Overview
10.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product Market Performance
10.14.4 Beijing United Family Rehabilitation Hospital Business Overview
10.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
10.15 Bionik Laboratories Corp
10.15.1 Bionik Laboratories Corp Neurorehabilitation Therapy Basic Information
10.15.2 Bionik Laboratories Corp Neurorehabilitation Therapy Product Overview
10.15.3 Bionik Laboratories Corp Neurorehabilitation Therapy Product Market Performance
10.15.4 Bionik Laboratories Corp Business Overview
10.15.5 Bionik Laboratories Corp Recent Developments
10.16 BioScience Managers Ltd
10.16.1 BioScience Managers Ltd Neurorehabilitation Therapy Basic Information
10.16.2 BioScience Managers Ltd Neurorehabilitation Therapy Product Overview
10.16.3 BioScience Managers Ltd Neurorehabilitation Therapy Product Market Performance
10.16.4 BioScience Managers Ltd Business Overview
10.16.5 BioScience Managers Ltd Recent Developments
10.17 Bioventus
10.17.1 Bioventus Neurorehabilitation Therapy Basic Information
10.17.2 Bioventus Neurorehabilitation Therapy Product Overview
10.17.3 Bioventus Neurorehabilitation Therapy Product Market Performance
10.17.4 Bioventus Business Overview
10.17.5 Bioventus Recent Developments
10.18 DIH (Hocoma AG)
10.18.1 DIH (Hocoma AG) Neurorehabilitation Therapy Basic Information
10.18.2 DIH (Hocoma AG) Neurorehabilitation Therapy Product Overview
10.18.3 DIH (Hocoma AG) Neurorehabilitation Therapy Product Market Performance
10.18.4 DIH (Hocoma AG) Business Overview
10.18.5 DIH (Hocoma AG) Recent Developments
10.19 Ekso Bionics Holdings
10.19.1 Ekso Bionics Holdings Neurorehabilitation Therapy Basic Information
10.19.2 Ekso Bionics Holdings Neurorehabilitation Therapy Product Overview
10.19.3 Ekso Bionics Holdings Neurorehabilitation Therapy Product Market Performance
10.19.4 Ekso Bionics Holdings Business Overview
10.19.5 Ekso Bionics Holdings Recent Developments
10.20 Eodyne
10.20.1 Eodyne Neurorehabilitation Therapy Basic Information
10.20.2 Eodyne Neurorehabilitation Therapy Product Overview
10.20.3 Eodyne Neurorehabilitation Therapy Product Market Performance
10.20.4 Eodyne Business Overview
10.20.5 Eodyne Recent Developments
10.21 Neofect
10.21.1 Neofect Neurorehabilitation Therapy Basic Information
10.21.2 Neofect Neurorehabilitation Therapy Product Overview
10.21.3 Neofect Neurorehabilitation Therapy Product Market Performance
10.21.4 Neofect Business Overview
10.21.5 Neofect Recent Developments
10.22 Neuro Rehab VR
10.22.1 Neuro Rehab VR Neurorehabilitation Therapy Basic Information
10.22.2 Neuro Rehab VR Neurorehabilitation Therapy Product Overview
10.22.3 Neuro Rehab VR Neurorehabilitation Therapy Product Market Performance
10.22.4 Neuro Rehab VR Business Overview
10.22.5 Neuro Rehab VR Recent Developments
10.23 Reha Technology AG
10.23.1 Reha Technology AG Neurorehabilitation Therapy Basic Information
10.23.2 Reha Technology AG Neurorehabilitation Therapy Product Overview
10.23.3 Reha Technology AG Neurorehabilitation Therapy Product Market Performance
10.23.4 Reha Technology AG Business Overview
10.23.5 Reha Technology AG Recent Developments
11 Neurorehabilitation Therapy Market Forecast by Region
11.1 Global Neurorehabilitation Therapy Market Size Forecast
11.2 Global Neurorehabilitation Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurorehabilitation Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Neurorehabilitation Therapy Market Size Forecast by Region
11.2.4 South America Neurorehabilitation Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Neurorehabilitation Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Neurorehabilitation Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Neurorehabilitation Therapy by Type (2025-2032)
12.1.2 Global Neurorehabilitation Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Neurorehabilitation Therapy by Type (2025-2032)
12.2 Global Neurorehabilitation Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Neurorehabilitation Therapy Sales (K MT) Forecast by Application
12.2.2 Global Neurorehabilitation Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurorehabilitation Therapy Market Size Comparison by Region (M USD)
Table 5. Global Neurorehabilitation Therapy Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Neurorehabilitation Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Neurorehabilitation Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Neurorehabilitation Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation Therapy as of 2022)
Table 10. Global Market Neurorehabilitation Therapy Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Neurorehabilitation Therapy Sales Sites and Area Served
Table 12. Manufacturers Neurorehabilitation Therapy Product Type
Table 13. Global Neurorehabilitation Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurorehabilitation Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurorehabilitation Therapy Market Challenges
Table 22. Global Neurorehabilitation Therapy Sales by Type (K MT)
Table 23. Global Neurorehabilitation Therapy Market Size by Type (M USD)
Table 24. Global Neurorehabilitation Therapy Sales (K MT) by Type (2019-2025)
Table 25. Global Neurorehabilitation Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Neurorehabilitation Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Neurorehabilitation Therapy Market Size Share by Type (2019-2025)
Table 28. Global Neurorehabilitation Therapy Price (USD/MT) by Type (2019-2025)
Table 29. Global Neurorehabilitation Therapy Sales (K MT) by Application
Table 30. Global Neurorehabilitation Therapy Market Size by Application
Table 31. Global Neurorehabilitation Therapy Sales by Application (2019-2025) & (K MT)
Table 32. Global Neurorehabilitation Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Neurorehabilitation Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Neurorehabilitation Therapy Market Share by Application (2019-2025)
Table 35. Global Neurorehabilitation Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Neurorehabilitation Therapy Sales by Region (2019-2025) & (K MT)
Table 37. Global Neurorehabilitation Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Neurorehabilitation Therapy Sales by Country (2019-2025) & (K MT)
Table 39. Europe Neurorehabilitation Therapy Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Neurorehabilitation Therapy Sales by Region (2019-2025) & (K MT)
Table 41. South America Neurorehabilitation Therapy Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Neurorehabilitation Therapy Sales by Region (2019-2025) & (K MT)
Table 43. Global Neurorehabilitation Therapy Production (K MT) by Region (2019-2025)
Table 44. Global Neurorehabilitation Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Neurorehabilitation Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Neurorehabilitation Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Neurorehabilitation Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Neurorehabilitation Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Neurorehabilitation Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Neurorehabilitation Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. VISHEE Neurorehabilitation Therapy Basic Information
Table 52. VISHEE Neurorehabilitation Therapy Product Overview
Table 53. VISHEE Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. VISHEE Business Overview
Table 55. VISHEE Neurorehabilitation Therapy SWOT Analysis
Table 56. VISHEE Recent Developments
Table 57. Beijing Bo'ai Hospital Neurorehabilitation Therapy Basic Information
Table 58. Beijing Bo'ai Hospital Neurorehabilitation Therapy Product Overview
Table 59. Beijing Bo'ai Hospital Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Beijing Bo'ai Hospital Business Overview
Table 61. Beijing Bo'ai Hospital Neurorehabilitation Therapy SWOT Analysis
Table 62. Beijing Bo'ai Hospital Recent Developments
Table 63. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Basic Information
Table 64. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product Overview
Table 65. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy SWOT Analysis
Table 67. Beijing Rehabilitation Hospital of Capital Medical University Business Overview
Table 68. Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
Table 69. NCC Neurorehabilitation Therapy Basic Information
Table 70. NCC Neurorehabilitation Therapy Product Overview
Table 71. NCC Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. NCC Business Overview
Table 73. NCC Recent Developments
Table 74. CHIEFTAIN Neurorehabilitation Therapy Basic Information
Table 75. CHIEFTAIN Neurorehabilitation Therapy Product Overview
Table 76. CHIEFTAIN Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. CHIEFTAIN Business Overview
Table 78. CHIEFTAIN Recent Developments
Table 79. Tongji Hospital Neurorehabilitation Therapy Basic Information
Table 80. Tongji Hospital Neurorehabilitation Therapy Product Overview
Table 81. Tongji Hospital Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Tongji Hospital Business Overview
Table 83. Tongji Hospital Recent Developments
Table 84. Haobro Medical Device Neurorehabilitation Therapy Basic Information
Table 85. Haobro Medical Device Neurorehabilitation Therapy Product Overview
Table 86. Haobro Medical Device Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Haobro Medical Device Business Overview
Table 88. Haobro Medical Device Recent Developments
Table 89. DIH Neurorehabilitation Therapy Basic Information
Table 90. DIH Neurorehabilitation Therapy Product Overview
Table 91. DIH Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. DIH Business Overview
Table 93. DIH Recent Developments
Table 94. Sun Java Neurorehabilitation Therapy Basic Information
Table 95. Sun Java Neurorehabilitation Therapy Product Overview
Table 96. Sun Java Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Sun Java Business Overview
Table 98. Sun Java Recent Developments
Table 99. Aoyang Health Neurorehabilitation Therapy Basic Information
Table 100. Aoyang Health Neurorehabilitation Therapy Product Overview
Table 101. Aoyang Health Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Aoyang Health Business Overview
Table 103. Aoyang Health Recent Developments
Table 104. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Basic Information
Table 105. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product Overview
Table 106. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. PKUCare Rehabilitation Hospital Business Overview
Table 108. PKUCare Rehabilitation Hospital Recent Developments
Table 109. Beijing Puhua International Hospital Neurorehabilitation Therapy Basic Information
Table 110. Beijing Puhua International Hospital Neurorehabilitation Therapy Product Overview
Table 111. Beijing Puhua International Hospital Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Beijing Puhua International Hospital Business Overview
Table 113. Beijing Puhua International Hospital Recent Developments
Table 114. Xiangyu Medical Neurorehabilitation Therapy Basic Information
Table 115. Xiangyu Medical Neurorehabilitation Therapy Product Overview
Table 116. Xiangyu Medical Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Xiangyu Medical Business Overview
Table 118. Xiangyu Medical Recent Developments
Table 119. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Basic Information
Table 120. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product Overview
Table 121. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Beijing United Family Rehabilitation Hospital Business Overview
Table 123. Beijing United Family Rehabilitation Hospital Recent Developments
Table 124. Bionik Laboratories Corp Neurorehabilitation Therapy Basic Information
Table 125. Bionik Laboratories Corp Neurorehabilitation Therapy Product Overview
Table 126. Bionik Laboratories Corp Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Bionik Laboratories Corp Business Overview
Table 128. Bionik Laboratories Corp Recent Developments
Table 129. BioScience Managers Ltd Neurorehabilitation Therapy Basic Information
Table 130. BioScience Managers Ltd Neurorehabilitation Therapy Product Overview
Table 131. BioScience Managers Ltd Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. BioScience Managers Ltd Business Overview
Table 133. BioScience Managers Ltd Recent Developments
Table 134. Bioventus Neurorehabilitation Therapy Basic Information
Table 135. Bioventus Neurorehabilitation Therapy Product Overview
Table 136. Bioventus Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Bioventus Business Overview
Table 138. Bioventus Recent Developments
Table 139. DIH (Hocoma AG) Neurorehabilitation Therapy Basic Information
Table 140. DIH (Hocoma AG) Neurorehabilitation Therapy Product Overview
Table 141. DIH (Hocoma AG) Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. DIH (Hocoma AG) Business Overview
Table 143. DIH (Hocoma AG) Recent Developments
Table 144. Ekso Bionics Holdings Neurorehabilitation Therapy Basic Information
Table 145. Ekso Bionics Holdings Neurorehabilitation Therapy Product Overview
Table 146. Ekso Bionics Holdings Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Ekso Bionics Holdings Business Overview
Table 148. Ekso Bionics Holdings Recent Developments
Table 149. Eodyne Neurorehabilitation Therapy Basic Information
Table 150. Eodyne Neurorehabilitation Therapy Product Overview
Table 151. Eodyne Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Eodyne Business Overview
Table 153. Eodyne Recent Developments
Table 154. Neofect Neurorehabilitation Therapy Basic Information
Table 155. Neofect Neurorehabilitation Therapy Product Overview
Table 156. Neofect Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 157. Neofect Business Overview
Table 158. Neofect Recent Developments
Table 159. Neuro Rehab VR Neurorehabilitation Therapy Basic Information
Table 160. Neuro Rehab VR Neurorehabilitation Therapy Product Overview
Table 161. Neuro Rehab VR Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 162. Neuro Rehab VR Business Overview
Table 163. Neuro Rehab VR Recent Developments
Table 164. Reha Technology AG Neurorehabilitation Therapy Basic Information
Table 165. Reha Technology AG Neurorehabilitation Therapy Product Overview
Table 166. Reha Technology AG Neurorehabilitation Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 167. Reha Technology AG Business Overview
Table 168. Reha Technology AG Recent Developments
Table 169. Global Neurorehabilitation Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 170. Global Neurorehabilitation Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America Neurorehabilitation Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 172. North America Neurorehabilitation Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe Neurorehabilitation Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 174. Europe Neurorehabilitation Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific Neurorehabilitation Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 176. Asia Pacific Neurorehabilitation Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America Neurorehabilitation Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 178. South America Neurorehabilitation Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa Neurorehabilitation Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa Neurorehabilitation Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global Neurorehabilitation Therapy Sales Forecast by Type (2025-2032) & (K MT)
Table 182. Global Neurorehabilitation Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global Neurorehabilitation Therapy Price Forecast by Type (2025-2032) & (USD/MT)
Table 184. Global Neurorehabilitation Therapy Sales (K MT) Forecast by Application (2025-2032)
Table 185. Global Neurorehabilitation Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Neurorehabilitation Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurorehabilitation Therapy Market Size (M USD), 2019-2032
Figure 5. Global Neurorehabilitation Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Neurorehabilitation Therapy Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurorehabilitation Therapy Market Size by Country (M USD)
Figure 11. Neurorehabilitation Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Neurorehabilitation Therapy Revenue Share by Manufacturers in 2023
Figure 13. Neurorehabilitation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurorehabilitation Therapy Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurorehabilitation Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurorehabilitation Therapy Market Share by Type
Figure 18. Sales Market Share of Neurorehabilitation Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Neurorehabilitation Therapy by Type in 2023
Figure 20. Market Size Share of Neurorehabilitation Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Neurorehabilitation Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurorehabilitation Therapy Market Share by Application
Figure 24. Global Neurorehabilitation Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Neurorehabilitation Therapy Sales Market Share by Application in 2023
Figure 26. Global Neurorehabilitation Therapy Market Share by Application (2019-2025)
Figure 27. Global Neurorehabilitation Therapy Market Share by Application in 2023
Figure 28. Global Neurorehabilitation Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Neurorehabilitation Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Neurorehabilitation Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Neurorehabilitation Therapy Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Neurorehabilitation Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Neurorehabilitation Therapy Sales Market Share by Country in 2023
Figure 37. Germany Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Neurorehabilitation Therapy Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Neurorehabilitation Therapy Sales Market Share by Region in 2023
Figure 44. China Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Neurorehabilitation Therapy Sales and Growth Rate (K MT)
Figure 50. South America Neurorehabilitation Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Neurorehabilitation Therapy Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Neurorehabilitation Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Neurorehabilitation Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Neurorehabilitation Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Neurorehabilitation Therapy Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Neurorehabilitation Therapy Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Neurorehabilitation Therapy Production (K MT) Growth Rate (2019-2025)
Figure 65. China Neurorehabilitation Therapy Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Neurorehabilitation Therapy Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Neurorehabilitation Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Neurorehabilitation Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Neurorehabilitation Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Neurorehabilitation Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Neurorehabilitation Therapy Market Share Forecast by Application (2025-2032)
